Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.
- Citation:
- J Clin Oncol vol 21 (9) 1819-24
- Year:
- 2003
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- CA31946
- Corr. Author:
- H L Parnes
- Authors:
- H L Parnes C Cirrincione J Aisner D A Berry S L Allen J Abrams E Chuang M R Cooper M C Perry D B Duggan T P Szatrowski I C Henderson L Norton
- Networks:
- Study
- CALGB-9140
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Cyclophosphamide, Disease Progression, Doxorubicin, Female, Fluorouracil, Health Status, Humans, Leucovorin, Middle Aged, Neoplasm Metastasis, Prognosis, Survival, Treatment Outcome, Viscera